DOMZALSKI DAVID (President and CEO) received a stock award from VYNE THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/2/2026ACC: 0001727794-26-000006
DirectorOfficer· President and CEO
Since Mar 2020
+30.79K
Net shares
Net buyer
$9.5K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
30.79K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+30.79K
Price / share
$0.31
Trade value
$9.55K
% of position
7.5%
5/29/2026
407.99K→438.78K
Total
Net shares
+30.79K
Net value
$9.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/29/2026 | A · Award | +30.79K | $0.31 | $9.55K | 7.5% | 407.99K | 438.78K |
| Total | +30.79K | $9.55K | ||||||
Derivative Transactions0
No derivative transactions reported